National Heart, Lung, and Blood Institute Twin Study

This study has been completed.
Sponsor:
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
NCT00005124
First received: May 25, 2000
Last updated: March 15, 2016
Last verified: May 2000
  Purpose
To assess genetic effects on the variation of cardiovascular and pulmonary risk factors in a cohort of 514 pairs of white male veteran twins.

Condition
Cardiovascular Diseases
Heart Diseases
Lung Diseases
Hypertension
Diabetes Mellitus
Obesity
Coronary Disease
Myocardial Ischemia

Study Type: Observational

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date: July 1969
Study Completion Date: November 1998
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   up to 100 Years   (Child, Adult, Senior)
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria
No eligibility criteria
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00005124

Sponsors and Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
OverallOfficial: Nemat Borhani
OverallOfficial: Dorit Carmelli
OverallOfficial: Margaret Chesney
OverallOfficial: Joe Christian
OverallOfficial: Gary Friedman
OverallOfficial: Marshall Greenberg
OverallOfficial: Clarence Grimm
OverallOfficial: Ray Rosenman
OverallOfficial: Makinodan Takashi
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00005124     History of Changes
Other Study ID Numbers: 903  R01HL051429 
Study First Received: May 25, 2000
Last Updated: March 15, 2016
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Diabetes Mellitus
Cardiovascular Diseases
Heart Diseases
Lung Diseases
Coronary Disease
Coronary Artery Disease
Myocardial Ischemia
Ischemia
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Respiratory Tract Diseases
Vascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on August 22, 2016